文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

IMI近视影响报告:全球负担、趋势与成本

IMI Impact of Myopia.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该综述分析近视对个体与社会的影响,汇总全球近视与高度近视患病率、终生病理表现、直接医疗支出及间接成本证据。主要趋势为近视与高度近视患病率上升,且高度近视增幅更大,预计未来因未矫正近视及高度近视并发症导致的视力损失将增加。当前全球直接医疗支出与生产力损失相关成本估计达数十亿美元。

要点

  • 2020年全球近30%人口患近视,预计2050年升至50%。
  • 高度近视患病率增幅更大,未来视力损失与并发症负担将加重。
  • 未矫正近视、高度近视及其并发症均影响生活质量,全球相关成本达数十亿美元。

核心结论

  • 近视与高度近视患病率持续上升且高度近视增幅更大,除非趋势改变,相关成本将继续增长。

研究设计与样本

  • 综述分析近年关于近视与高度近视患病率、终生病理表现、直接医疗支出及间接成本的研究证据。

主要发现

  • 2020年近视影响全球近30%人口,预计2050年升至50%。
  • 高度近视患病率增幅不成比例地更大, forecast 未来因未矫正近视及高度近视相关并发症如近视性黄斑变性导致的视力损失增加。
  • 未矫正近视、高度近视或高度近视并发症患者的生活质量受影响。
  • 当前全球直接医疗支出与生产力损失相关成本估计达数十亿美元,成人医疗支出更高反映近视相关并发症的额外成本。

临床怎么用

  • 需关注近视与高度近视患病率上升趋势,重视未矫正近视及高度近视并发症的视力损失风险。
  • 评估近视相关直接医疗支出与生产力损失等间接成本,成人并发症相关支出更高。
  • 近年出现多种预防和延缓近视的新方法,需进一步研究其终生影响与成本效益。

局限性

  • 需进一步研究理解近视对个体的终生影响及各种新方法降低负担的成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The global burden of myopia is growing. Myopia affected nearly 30% of the world population in 2020 and this number is expected to rise to 50% by 2050. This review aims to analyze the impact of myopia on individuals and society; summarizing the evidence for recent research on the prevalence of myopia and high myopia, lifetime pathological manifestations of myopia, direct health expenditure, and indirect costs such as lost productivity and reduced quality of life (QOL). The principal trends are a rising prevalence of myopia and high myopia, with a disproportionately greater increase in the prevalence of high myopia. This forecasts a future increase in vision loss due to uncorrected myopia as well as high myopia-related complications such as myopic macular degeneration. QOL is affected for those with uncorrected myopia, high myopia, or complications of high myopia. Overall the current global cost estimates related to direct health expenditure and lost productivity are in the billions. Health expenditure is greater in adults, reflecting the added costs due to myopia-related complications. Unless the current trajectory for the rising prevalence of myopia and high myopia change, the costs will continue to grow. The past few decades have seen the emergence of several novel approaches to prevent and slow myopia. Further work is needed to understand the life-long impact of myopia on an individual and the cost-effectiveness of the various novel approaches in reducing the burden.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sankaridurg P, Tahhan N, Kandel H, et al. IMI Impact of Myopia. Invest Ophthalmol Vis Sci. 2021. PMID: 33909036. doi:10.1167/iovs.62.5.2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。